These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 378799

  • 21. [Liver damage caused by psychopharmaceuticals].
    Altomare E, Vendemiale G, Procacci V, Giovine A, Di Reda N, Albano O.
    Clin Ter; 1989 Nov 30; 131(4):247-51. PubMed ID: 2532094
    [Abstract] [Full Text] [Related]

  • 22. [Experiences with Vitamin B-12 therapy of chronic liver diseases in a resort practice].
    André W.
    Munch Med Wochenschr; 1966 Mar 18; 108(11):610-1. PubMed ID: 6013869
    [No Abstract] [Full Text] [Related]

  • 23. [Hepatitis caused by exifone].
    Pariente EA, Kapfer J.
    Gastroenterol Clin Biol; 1989 Apr 18; 13(4):426. PubMed ID: 2737395
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Exifone: 4 cases of hepatitis].
    Chichmanian RM, Mignot G, Brucker F, Greck T, Spreux A.
    Gastroenterol Clin Biol; 1989 Apr 18; 13(4):428-9. PubMed ID: 2737398
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Severe acute hepatic involvements caused by exifone].
    Ouzan D, Chichmanian RM, Fuzibet JG, Saint-Paul M, Fredendrich A.
    Therapie; 1990 Apr 18; 45(5):436-7. PubMed ID: 2260042
    [No Abstract] [Full Text] [Related]

  • 29. [Liver disease induced by psychiatric drugs].
    Lamela CA.
    Vertex; 2005 Apr 18; 16(59):29-34. PubMed ID: 15785786
    [Abstract] [Full Text] [Related]

  • 30. [Exifone, a new hepatotoxic drug?].
    Larrey D.
    Gastroenterol Clin Biol; 1989 Apr 18; 13(4):333-4. PubMed ID: 2737388
    [No Abstract] [Full Text] [Related]

  • 31. [Controlled clinical evaluation of cicloxilic acid in hepatopathies caused by psychopharmacological agents].
    Bocci U, Beretta G.
    Clin Ter; 1980 May 31; 93(4):373-88. PubMed ID: 6998639
    [No Abstract] [Full Text] [Related]

  • 32. [Experimental results and therapeutic activity of a protein-free hepatic extract in cases of hepatobiliary disorders of surgical importance].
    Boselli G.
    Minerva Med; 1967 Oct 31; 58(87):3725-33. PubMed ID: 6075228
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Guidelines for clinical trials of psychotropic drugs June 1, 1977.
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Jul 31; 10(4):205-31. PubMed ID: 360242
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Hepatic injury associated with the phenothiazines. Clinicopathologic and follow-up study of 36 patients.
    Ishak KG, Irey NS.
    Arch Pathol; 1972 Apr 31; 93(4):283-304. PubMed ID: 5017281
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Anatomo-pathological changes in the biliary system caused by povidone iodide. Experimental study].
    Reyes M, Moyano T, Martínez R, Arévalo E, Pera C.
    Rev Esp Enferm Apar Dig; 1989 Oct 31; 76(4):339-47. PubMed ID: 2595066
    [Abstract] [Full Text] [Related]

  • 39. [Principles and regulations for clinical pilot studies on psycholeptic drugs (author's transl)].
    Woggon B, Angst J.
    Arzneimittelforschung; 1978 Oct 31; 28(8):1257-9. PubMed ID: 380573
    [Abstract] [Full Text] [Related]

  • 40. [Therapeutic evaluation of 4-methylumbelliferone in biliary diseases by a double blind method].
    Hirayama C, Okumura M, Nakane M, Baba K, Furukawa K.
    Nihon Shokakibyo Gakkai Zasshi; 1972 Jan 31; 69(1):104-13. PubMed ID: 4573687
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.